Veronica McGregor is an Endocrinology/Metabolic physician affiliated with Washington University in St. Louis. OpenAlex indexes 5 publications with 351 citations (h-index 4).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
621 S New Ballas Rd
Suite 460-A
Saint Louis, MO 631418232
Telephone
314-251-4330Registry record last updated 6 Jun 2011.
Industry payments
44 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Sequel Med Tech, LLCProgram year202520 payments
- Dexcom, Inc.Program year202511 payments
- Novo Nordisk IncProgram year20259 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
57%Insulin Analog16.7%Tresiba Flextouch U-10018%Lantus Solostar14%Tresiba Flextouch U-20012%Humalog Kwikpen U-10011%Novolog Flexpen10%Humalog6%Novolog6%Toujeo Solostar5%Fiasp Flextouch4%Humalog Kwikpen U-2003%Basaglar Kwikpen U-1002%Insulin Lispro Kwikpen U-1002%Soliqua 100-332%Insulin Aspart Flexpen2%Levemir Flexpen1%Insulin Lispro1%Lantus1%Toujeo Max Solostar1%Part D<11 patientsGLP-1 receptor agonist13.3%Ozempic66%Mounjaro22%Trulicity10%Victoza 3-Pak3%Part D<11 patients+ 10 more classes in this area
Cardiovascular
17.9%Statin7.1%Atorvastatin Calcium55%Rosuvastatin Calcium27%Pravastatin Sodium12%Simvastatin7%Part D<11 patientsAngiotensin receptor blocker (ARB)2.6%Losartan Potassium60%Olmesartan Medoxomil31%Irbesartan9%Part D<11 patients+ 9 more classes in this area
Hormonal (systemic)
15.5%l-Thyroxine12.9%Levothyroxine Sodium75%Synthroid25%Part D≥159 patientsThyroid Hormone Synthesis Inhibitor1.7%Methimazole100%Part D≥23 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Elevated endogenous cortisol reduces autonomic neuroendocrine and symptom responses to subsequent hypoglycemia
American Journal of Physiology-Endocrinology and Metabolism
2002
Similar KOLs
Other experts from the same institution or the same specialty.
Timothy Ley, MD
Washington University in St. Louis
David Gutmann, MD
Washington University in St. Louis
Randall Bateman, MD
Washington University in St. Louis
Victoria Fraser, MD
Washington University in St. Louis
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”